Ranitidine Hydrochloride

CHEMBL2110372 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
350.9 g/mol
LogP
Phase
4

The hydrochloride salt form of ranitidine used to reduce stomach acid and treat conditions like peptic ulcers and gastroesophageal reflux disease. This formulation was widely prescribed before safety concerns led to its market withdrawal.

Peso molecular

350,8700 g/mol

TPSA

112,00 Ų

Áreas terapéuticas

Mecanismo de acción

Competitive H2 receptor antagonist.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Competitive H2 receptor antagonist.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl

InChI

InChI=1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H

Molecular Formula

C13H23ClN4O3S

HBD / HBA

3 / 7

Enlaces Rotables

9

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The hydrochloride salt form of ranitidine used to reduce stomach acid and treat conditions like peptic ulcers and gastroesophageal reflux disease. This formulation was widely prescribed before safety concerns led to its market withdrawal.

Competitive H2 receptor antagonist.

Yes, Ranitidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110372. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3033332. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.